Literature DB >> 22886308

Osteopenia/osteoporosis in patients with calcium nephrolithiasis.

Miguel Angel Arrabal-Polo1, Miguel Arrabal-Martin, Maria Sierra Girón-Prieto, Antonio Poyatos-Andujar, Juan Garrido-Gomez, Armando Zuluaga-Gomez, Salvador Arias-Santiago.   

Abstract

The objective of this study is to analyze the alterations in bone mineral density and bone and calcium-phosphorus metabolism in patients with calcium nephrolithiasis. We designed a study with 182 patients who were distributed among three groups: group O, 56 patients without nephrolithiasis; group A, 67 patients with calcium nephrolithiasis and mild lithogenic activity; and group B, 59 patients with calcium nephrolithiasis and severe lithogenic activity. Metabolic parameters of blood and urine that were related to calcium-phosphorous and bone metabolism and bone densitometry were assessed in all patients. A comparative study was performed on the variables of bone and calcium-phosphorus metabolism and bone densitometry as well as the presence or absence of osteopenia/osteoporosis. The patients in group B had a greater loss of bone mineral density, measured by the T-score, than the patients in groups O and A. Moreover, the proportion of patients in group B with osteopenia/osteoporosis was statistically significantly higher than the proportion of patients in groups O and A. We observed higher values of calciuria, fasting calcium/creatinine ratio, and 24-h calcium/creatinine among the patients in group B compared to the other two groups. Calciuria, citraturia, and fasting calcium/creatinine were independent factors that showed a relationship with severe lithogenic activity compared to the control group, and β-crosslaps is an independent factor that has a relationship with severe lithogenic activity as compared to mild lithogenic activity. Patients with calcium lithiasis and severe lithogenic activity have a greater loss in bone mineral density and therefore a greater risk of osteopenia/osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22886308     DOI: 10.1007/s00240-012-0497-8

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  28 in total

1.  Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis.

Authors:  John R Asplin; Kimberly A Bauer; Jennifer Kinder; Georg Müller; Brian J Coe; Joan H Parks; Fredric L Coe
Journal:  Kidney Int       Date:  2003-02       Impact factor: 10.612

2.  Stones, bones, and heredity.

Authors:  Dawn S Milliner
Journal:  Acta Paediatr Suppl       Date:  2006-07

3.  Stones and bones: bone resorption and metabolism in stoneformers.

Authors:  R A Sutton
Journal:  Curr Opin Urol       Date:  1998-07       Impact factor: 2.309

4.  Determinants of osteopenia in male renal-stone-disease patients with idiopathic hypercalciuria.

Authors:  Emmanuel Letavernier; Olivier Traxer; Michel Daudon; Mohammed Tligui; Jérôme Hubert-Brierre; Dominique Guerrot; Aline Sebag; Laurent Baud; Jean-Philippe Haymann
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-24       Impact factor: 8.237

5.  Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria.

Authors:  J R Weisinger; E Alonzo; E Bellorín-Font; A M Blasini; M A Rodriguez; V Paz-Martínez; R Martinis
Journal:  Kidney Int       Date:  1996-01       Impact factor: 10.612

6.  Normocalcemic hyperparathyroidism in patients with recurrent kidney stones: a disease entity or vitamin D deficiency?

Authors:  Chrysoula Pipili; Nigar Sekecioglu; Dimitrios G Oreopoulos
Journal:  Clin Nephrol       Date:  2012-05       Impact factor: 0.975

7.  Bone density and skeletal metabolism are altered in idiopathic hypercalciuria.

Authors:  S Giannini; M Nobile; L Sartori; L Calò; A Tasca; L Dalle Carbonare; M Ciuffreda; A D'Angelo; F Pagano; G Crepaldi
Journal:  Clin Nephrol       Date:  1998-08       Impact factor: 0.975

8.  Bone alterations in children with idiopathic hypercalciuria at the time of diagnosis.

Authors:  Maria-Goretti Moreira Guimarães Penido; Eleonora Moreira Lima; Viviane Santuari Parizotto Marino; Ana-Luiza Fialho Tupinambá; Anderson França; Marcelo Ferraz Oliveira Souto
Journal:  Pediatr Nephrol       Date:  2002-12-19       Impact factor: 3.714

9.  Aetiology and clinical characteristics of male osteoporosis. Have they changed in the last few years?

Authors:  P Peris; A Martínez-Ferrer; A Monegal; M J Martínez de Osaba; L Alvarez; I Ros; A Muxí; R Reyes; N Guañabens
Journal:  Clin Exp Rheumatol       Date:  2008 Jul-Aug       Impact factor: 4.473

10.  Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors.

Authors:  Renata Caudarella; Fabio Vescini; Angela Buffa; Giuseppe Sinicropi; Elisabetta Rizzoli; Gaetano La Manna; Sergio Stefoni
Journal:  J Nephrol       Date:  2003 Mar-Apr       Impact factor: 3.902

View more
  4 in total

1.  Urinary stone risk factors in the descendants of patients with kidney stone disease.

Authors:  Thasinas Dissayabutra; Nuttiya Kalpongkul; Jakkhaphan Rattanaphan; Chanchai Boonla; Monpicha Srisa-Art; Wattanachai Ungjaroenwathana; Piyaratana Tosukhowong
Journal:  Pediatr Nephrol       Date:  2018-03-28       Impact factor: 3.714

2.  The importance of urinary calcium in postmenopausal women with osteoporotic fracture.

Authors:  Miguel Angel Ochoa-Hortal Rull; María Del Carmen Cano-García; Miguel Arrabal-Martín; Miguel Angel Arrabal-Polo
Journal:  Can Urol Assoc J       Date:  2015 Mar-Apr       Impact factor: 1.862

3.  The importance of calciuria as lithogenic factors in patients with osteopenia/osteoporosis.

Authors:  Miguel Arrabal-Martin; Antonio Poyatos-Andujar; María del Carmen Cano-García; Miguel Quesada-Charneco; Felix Abad-Menor; María Sierra Girón Prieto; Tomás de Haro Muñoz; Miguel Angel Arrabal-Polo
Journal:  Int Urol Nephrol       Date:  2015-02-05       Impact factor: 2.370

Review 4.  Nephrolithiasis, bone mineral density, osteoporosis, and fractures: a systematic review and comparative meta-analysis.

Authors:  P Lucato; C Trevisan; B Stubbs; B M Zanforlini; M Solmi; C Luchini; G Girotti; S Pizzato; E Manzato; G Sergi; S Giannini; M Fusaro; N Veronese
Journal:  Osteoporos Int       Date:  2016-06-11       Impact factor: 4.507

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.